XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
shares in Thousands
 3 Months Ended
Feb. 28, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the quarter ended February 28, 2025, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1 Plan”), were as follows:

NameTitleActionDate AdoptedExpiration DateAggregate # of Securities to be Purchased/Sold
Dr. Daniel Weiner (1)
DirectorTermination01/17/202301/27/20259,874 
Dr. Daniel Weiner (2)
DirectorTermination02/06/202402/08/202512,000 
Dr. Lisa LaVange (3)
DirectorTermination02/06/202402/08/20254,600 

(1) On January 27, 2025, the pre-arranged stock trading plan pursuant to Rule 10b5-1, adopted by Dr. Daniel Weiner on January 17, 2023, automatically terminated pursuant to its terms. The expired plan provided for (i) the potential exercise of vested stock options and the associated sale of up to up to 6,000 shares of Company common stock underlying such options, and (ii) the potential sale of up to an additional 3,874 shares of Company common stock.

(2) On February 8, 2025, the pre-arranged stock trading plan pursuant to Rule 10b5-1, adopted by Dr. Daniel Weiner on February 6, 2024, automatically terminated pursuant to its terms. The expired plan provided for (i) the potential exercise of vested stock options and the associated sale of up to up to 6,000 shares of Company common stock underlying such options, and (ii) the potential sale of up to an additional 6,000 shares of Company common stock.

(3) On February 8, 2025, the pre-arranged stock trading plan pursuant to Rule 10b5-1, adopted by Dr. Lisa LaVange on February 6, 2024, automatically terminated pursuant to its terms. The expired plan provided for (i) the potential exercise of vested stock options and the associated sale of up to up to 1,000 shares of Company common stock underlying such options, and (ii) the potential sale of up to an additional 3,600 shares of Company common stock.
The Rule 10b5-1 trading arrangements described above were adopted and precleared in accordance with the Company’s Insider Trading Policy and actual sale transactions made pursuant to such trading arrangements will be disclosed publicly in future Section 16 filings with the SEC.
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Dr. Lisa LaVange [Member]  
Trading Arrangements, by Individual  
Name Dr. Lisa LaVange (3)
Title Director
Rule 10b5-1 Arrangement Terminated true
Termination Date February 8, 2025
Aggregate Available 4,600
Dr. Daniel Weiner, Termination Plan 1 [Member] | Dr. Daniel Weiner [Member]  
Trading Arrangements, by Individual  
Name Dr. Daniel Weiner (1)
Title Director
Rule 10b5-1 Arrangement Terminated true
Termination Date January 27, 2025
Aggregate Available 9,874
Dr. Daniel Weiner, Termination Plan 2 [Member] | Dr. Daniel Weiner [Member]  
Trading Arrangements, by Individual  
Name Dr. Daniel Weiner (2)
Title Director
Rule 10b5-1 Arrangement Terminated true
Termination Date February 8, 2025
Aggregate Available 12,000